Anzeige
Mehr »
Samstag, 05.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PURU | ISIN: HK0000544194 | Ticker-Symbol:
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
SINOMAB BIOSCIENCE LTD Chart 1 Jahr
5-Tage-Chart
SINOMAB BIOSCIENCE LTD 5-Tage-Chart

Aktuelle News zur SINOMAB BIOSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoSINOMAB BIO-B (03681): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE ADOPTED BY THE BOARD ON 30 JUNE, 20251
SINOMAB BIOSCIENCE Aktie jetzt für 0€ handeln
MoSINOMAB BIO-B (03681): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS1
MoSINOMAB BIO-B (03681): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2025, APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS, CHANGE IN ...-
12.06.SINOMAB BIO-B (03681): RESIGNATION OF EXECUTIVE DIRECTOR-
11.06.SINOMAB BIO-B (03681): POSTPONEMENT AND CHANGE OF VENUE OF ANNUAL GENERAL MEETING AND CHANGE OF BOOK CLOSURE PERIOD1
09.06.SINOMAB BIO-B (03681): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS-
09.06.SINOMAB BIO-B (03681): PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND WITHDRAWAL OF ORDINARY RESOLUTION NO. 2(D) AT THE ANNUAL GENERAL MEETING-
06.06.SINOMAB BIO-B (03681): VOLUNTARY ANNOUNCEMENT CESSATION TO ACT AS PRESIDENT (CHINA)1
29.05.SINOMAB BIO-B (03681): NEXT DAY DISCLOSURE RETURN-
29.05.SINOMAB BIO-B (03681): COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE3
13.05.SINOMAB BIO-B (03681): SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE-
24.04.SINOMAB BIO-B (03681): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT1
24.04.SINOMAB BIO-B (03681): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM-
24.04.SINOMAB BIO-B (03681): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM-
24.04.SINOMAB BIO-B (03681): NOTICE OF 2025 ANNUAL GENERAL MEETING3
24.04.SINOMAB BIO-B (03681): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 3, 14/F, FAIRMONT HOUSE, 8 COTTON TREE DRIVE, CENTRAL, HONG KONG ...1
24.04.SINOMAB BIO-B (03681): PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND ...-
24.04.SINOMAB BIO-B (03681): ANNUAL REPORT 2024-
09.04.SinoMab BioScience Limited Breakthrough Phase 1b POC Results for SM17 in Atopic Dermatitis342- Potentially a First-and Best-in-Class Product- Combining Deep Pruritus Relief, Effective Skin Clearance, and a Well-tolerated Safety ProfileHONG KONG, Apr 9, 2025 - (ACN Newswire) - SinoMab BioScience...
► Artikel lesen
07.04.SINOMAB BIO-B (03681): INSIDE INFORMATION POSITIVE TOPLINE RESULTS FROM PHASE 1B CLINICAL TRIAL OF SM17 IN CHINA FOR THE TREATMENT OF MODERATE-TO-SEVERE ...1
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1